Literature DB >> 23810221

Pharmacotherapy for alcohol dependence: status of current treatments.

Johan Franck1, Nitya Jayaram-Lindström.   

Abstract

The efficacy of medications for alcohol dependence remains modest, and there are no strong clinical predictors of treatment response. Approved medications include acamprosate (an N-methyl-d-aspartate receptor (NMDA) modulator), disulfiram (an acetaldehyde dehydrogenase inhibitor) and naltrexone (an opioid antagonist) while nalmefene (an opioid antagonist) is currently under review for approval in Europe. Clinical trials suggest that baclofen (a GABA-B agonist) and topiramate (an anticonvulsant) may be promising candidates, while several other drug candidates are currently evaluated at early clinical stages.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23810221     DOI: 10.1016/j.conb.2013.05.005

Source DB:  PubMed          Journal:  Curr Opin Neurobiol        ISSN: 0959-4388            Impact factor:   6.627


  28 in total

Review 1.  Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches.

Authors:  Pedro N Batalha; Luana S M Forezi; Carolina G S Lima; Fernanda P Pauli; Fernanda C S Boechat; Maria Cecília B V de Souza; Anna C Cunha; Vitor F Ferreira; Fernando de C da Silva
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

Review 2.  Alcohol-induced dysregulation of stress-related circuitry: The search for novel targets and implications for interventions across the sexes.

Authors:  T A Retson; R C Sterling; E J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-05-23       Impact factor: 5.067

Review 3.  Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.

Authors:  Lars Oreland; Gianvito Lagravinese; Simone Toffoletto; Kent W Nilsson; Jaanus Harro; C Robert Cloninger; Erika Comasco
Journal:  J Neural Transm (Vienna)       Date:  2017-01-04       Impact factor: 3.575

4.  Effect of Zhubin (KI9) acupuncture in reducing alcohol craving in patients with alcohol dependence: A randomized placebo-controlled trial.

Authors:  Jin-Seong Lee; Sung-Gon Kim; Taek-Geun Jung; Woo Young Jung; Seong-Yeon Kim
Journal:  Chin J Integr Med       Date:  2014-09-24       Impact factor: 1.978

Review 5.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

6.  Chronic alcohol exposure differentially affects activation of female locus coeruleus neurons and the subcellular distribution of corticotropin releasing factor receptors.

Authors:  T A Retson; B A Reyes; E J Van Bockstaele
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-08-20       Impact factor: 5.067

Review 7.  Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment.

Authors:  James J Mahoney; Colleen A Hanlon; Patrick J Marshalek; Ali R Rezai; Lothar Krinke
Journal:  J Neurol Sci       Date:  2020-09-20       Impact factor: 3.181

Review 8.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

Review 9.  Addictive behaviour in experimental animals: prospects for translation.

Authors:  Barry J Everitt; Chiara Giuliano; David Belin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

10.  Alcohol-induced behavioral changes in zebrafish: The role of dopamine D2-like receptors.

Authors:  Steven Tran; Amanda Facciol; Robert Gerlai
Journal:  Psychopharmacology (Berl)       Date:  2016-03-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.